Non-A, Non-B Hepatitis: Sorting through a Diagnosis of Exclusion
Authors: Miriam J. Alter
Journal: Annals of Internal Medicine (1989)

Editorials15 April 1989Non-A, Non-B Hepatitis: Sorting through a Diagnosis of ExclusionMiriam J. Alter, PhDMiriam J. Alter, PhDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-110-8-583 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSince the development of diagnostic tests for hepatitis B virus and its elimination as the major cause of transfusion-associated hepatitis, non-A, non-B hepatitis has been recognized by a diagnosis of exclusion. Although many putative agents and diagnostic assays have been reported, none has stood the test of time, and those searching for the elusive cause of this disease have been frustrated. The plight of clinicians has also been frustrating as they have to explain the meaning of non-A, non-B hepatitis to patients and to blood donors who have abnormal alanine aminotransferase (ALT) levels or antibody to hepatitis B core antigen...References1. AlterHadlerFrancisMaynard MSDJ. The epidemiology of non-A, non-B hepatitis in the United States. In: Dodd RY, Barker LF, eds. Infection, Immunity, and Blood Transfusion. New York: Alan R. Liss, Inc.; 1985:71-9. Google Scholar2. AlterPurcellHolland HRP. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975;2:838-41. CrossrefMedlineGoogle Scholar3. Dienstag J. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983;85:439-62. CrossrefMedlineGoogle Scholar4. AlterGeretySmallwood MRL. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis. 1982;145:886-93. CrossrefMedlineGoogle Scholar5. AlterHadlerMargolis MSH. The changing epidemiology of non-A, non-B hepatitis in the United States: relationship to transfusions, abstracted. Transfusion-Associated Infections and Immune Response. 1988; III.1, p.14. Google Scholar6. AachLanderSherman RJL. Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and nontransfused patients. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1978:383-96. Google Scholar7. HoofnaglePonzettoMathiesenWaggonerBalesSeeff JALJZL. Serological diagnosis of acute viral hepatitis. Dig Dis Sci. 1985;30:1022-7. CrossrefMedlineGoogle Scholar8. SamplinerWoronowAlter RDM. Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity. J Med Virol. 1984;13:125-30. CrossrefMedlineGoogle Scholar9. SeeffWrightZimmerman LEH. VA cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci. 1975;270:355-62. CrossrefMedlineGoogle Scholar10. AlterPurcellFeinstoneHollandMorrow HRSPA. Non-A, non-B hepatitis: a review and interim report of an ongoing prospective study. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1978:359-69. Google Scholar11. DienstagAlter JH. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspectives. Semin Liver Dis. 1986;6:67-81. CrossrefMedlineGoogle Scholar12. Alter H. The chronic consequences of non-A, non-B hepatitis. In: Seeff LB, ed. Current Perspectives in Hepatology. New York: Plenum Publishing Corp.; 1989:[in press]. CrossrefGoogle Scholar13. AlterMargolisKrawczynski MHK. The role of transfusions in the chronic disease burden associated with non-A, non-B hepatitis in the United States, abstracted. Transfusion-Associated Infections and Immune Response 1988, III.4, p.15. Google Scholar14. BradleyMaynardPopper DJH. Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis. 1983;148:254-65. CrossrefMedlineGoogle Scholar15. WongPurcellSreenivasan DRM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980;2:876-9. CrossrefMedlineGoogle Scholar16. KaneBradleyShrestha MDS. Epidemic non-A, nonB hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 1984;252:3140-5. CrossrefMedlineGoogle Scholar17. Enterically transmitted non-A, non-B hepatitis—Mexico. MMWR. 1987;36:597-602. MedlineGoogle Scholar18. RamalingaswamiPurcell VR. Waterborne non-A, non-B hepatitis. Lancet. 1988;1:571-3. CrossrefMedlineGoogle Scholar19. BradleyAndjaparidzeCook DAE. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol. 1988;69:731-8. CrossrefMedlineGoogle Scholar20. ArankalleTicehurstSreenivasan VJM. Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis. Lancet. 1988;1:550-4. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Centers for Disease Control Atlanta, Georgia PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMechanisms of Cell Entry of Hepatitis C VirusEnhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004National Surveillance of Dialysis‐Associated Diseases in the United States, 1997GB Virus C (GBV-C/HGV) and E2 Antibodies in Children Preliver and Postliver TransplantHepatitis C virus: models of immunopathogenesis and prophylaxisInfluence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis CAcute sporadic hepatitis E virus infection in southern ChinaFrequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assaysPrevalence and Consistency of ALT Elevation in Plasmapheresis Donors: Implications for the Assessment of Blood Product InfectivityConsequences of chronic hepatitis C: A review article for the hematologistTransfusion-Associated Hepatitis C: Reducing the RiskChronic liver disease in asymptomatic hepatitis C antibody positive blood donorsRisiken der homologen Bluttransfusionα-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markersEnzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian childrenInterferon therapy of cryptogenic chronic active liver disease and its relationship to anti-HCVProblematiche Inerenti L'epatite C Nei Centri DialisiInteraction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseasesAntibody to hepatitis C virus in cryptogenic chronic liver diseaseDiscrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapyPossibility of heterosexual transmission of hepatitis C virusHepatitis NANB/C: klinisches Bild und KrankheitsverlaufLow prevalence of antibody to hepatitis C virus in North East EnglandHaematology.Hepatitis C Virus Infection in Patients with Nonalcoholic Chronic Liver DiseaseJosé M. Sánchez-Tapias, MD, Josep M. Barrera, MD, Josep Costa, PhD, MarÍa G. Ercilla, MD, Albert Parés, MD, Lluis Comalrrena, MD, Francesc Soley, MD, Jordi Bruix, MD, Xavier Calvet, MD, MarÍa P. Gil, MD, Antoni Mas, MD, Miquel Bruguera, MD, Ricard Castillo, MD, Joan Rodés, MDAn Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisDiscovery of the Non-A, Non-B Hepatitis Virus: The End of the Beginning or the Beginning of the End 15 April 1989Volume 110, Issue 8Page: 583-585KeywordsAlanine aminotransferaseAntigensBlood donorsHepatitisHepatitis A virusHepatitis BHepatitis B virus Issue Published: 15 April 1989 PDF downloadLoading ...